Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5401_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
224 Herbal Pharmacopeia
156.25, and 78.125 μg/mL, there were no visible bacterial colonies during the exposure time. The descriptive analysis was followed by a statistical analysis, which showed that there was a signicant reduction of bacterial numbers in the MWCNT- LVX treatment groups in comparison to the control groups, where p < 0.02, indicating that the medication through the MWCNT- LVX delivery system was better able to convey. The nontreated group had the most bacterial colonies per milliliter, while those treated with MWCNT- LVX had signicantly fewer colonies (p < 0.005) (Hassani etal., 2022). Titanium alloys have recently received a lot of attention for their use in bone implants. For these rea­sons, the use of titanium alloys in bone implants is hampered by various constraints, such as metal incompatibility, callus formation, and delayed fracture healing. It developed anodic oxidation with a TiO2 nanotubular layer for enhanced surface biocompatibility. In this, an antimicrobial characteristic was given by coating it with curcumin. A curcumin drug loading on the TiO2 surface was prepared by the direct dropping method. The results from the antibacterial activity conrm the report that the E. coli and S. aureus bacteria populations are cut back by 43% and 38%, respectively, in a 24-hour period. This research showed that the curcumin coat did not promote the rates at which the hMSCs had proliferated relative to a polished surface. It was, however, more favourable for the attachment of stem cells (Saha etal., 2021). Medicinal nanotechnology with an antibacterial property holds great prospects for the ght against bacterial infections. It will provide more effective and targeted, safe antibacterial therapeutics if developed to exploit the multiple cutting- edge advantages that only nanotechnology can offer in the future. It is along these lines that future studies are likely to greatly benet to bringing signicant advancement in the management of bacterial diseases and help com­bat the growing menace of antibiotic resistance.

10.3.4 aNtifuNgal herbal NaNomediciNe

Fungal infection has emerged as a signicant public health threat among patients whose immunity has been compromised, hospitalized, and chronic patients, and patients undergoing organ transplan­tation. These diseases are increasingly prevalent and fatal, all because of the potent property of the microorganism due to which resistant strains have developed against current treatments. The main factors responsible for the resistance include the emergence of new strains and unrestricted usage of antifungal drugs. For this reason, the medical fraternity must devise new mechanisms that assist in ghting such infections. Natural products, of course, have the greatest potential for developing new drugs for fungal infections due to their biocompatibility and low toxicology. Antibacterial activities and natural products are mainly aimed at avonoids, terpenes, and quinones, accounting for antifun­gal activities. These are studied to increase the pharmaceutical drug's transportation, specicity, and medical effectiveness. Nanotechnological systems can provide a secure and specic environment for different chemicals, including natural products, thereby enhancing their antifungal efcacy (Marena et al., 2022). The efciency of hydrogel containing terbinane hydrochloride- loaded solid lipid nanoparticles was evaluated in vivo in a rat mycosis model generated by C. albicans. The results revealed a substantial reduction in Candida infection with the use of this hydrogel. In the culture test, just two of the seven animals tested positive and were infected, whereas the controls had higher rates. The hydrogel containing solid lipid nanoparticles (SLN) with terbinane (TH) demonstrated efcacy comparable to commercially available terbinane formulations, while requiring less frequent appli­cations than the latter. The hydrogel can be repurposed as a sustained release treatment, requiring fewer doses (p < 0.05).(Rarokar etal., 2022). The antifungal activity of AgNPs was produced from Alhagi graecorum plant leaves and evaluated against several Candida species using the well diffu­sion method. The results showed inhibitory zones of 14–22 mm at a concentration of 0.01 mmol/ml and 16–27 mm at a concentration of 0.02 mmol/ml. The ndings were signicantly superior than those obtained with the AgNO3 solution alone, 8–11 mm, and uconazole, whose zone of inhibition is within the range 3–5 mm (Hawar etal., 2022). The in vitro experiment demonstrated that pome­granate and orange peel extracts, as well as their biosynthesized AgNPs, effectively inhibited A. solani mycelia at all concentrations tested. AgNPs inhibited mycelial development more effectively
Applications of Nanotechnology in Herbal Pharmacology 225
than peel extracts and AgNO3. At a concentration of 100 μg/mL, pomegranate peel extract reduced mycelial growth by 6.12 cm, AgNPs by 16.14 cm, and AgNO3 by 14.12 cm. Similarly, the orange peel extract reduced mycelial development by 5.21 cm, the AgNPs by 12.52 cm, and the AgNO3 by 10.61 cm. Among the various treatments, the pomegranate peel extract and its AgNPs showed better efcacy compared to the orange peel extract and its AgNPs (Mostafa etal., 2021). Currently, the rapid increase in the number of multidrug resistant fungal strains necessitates the development of new natural antifungal categories as well as a unique drug delivery mechanism. Medical plant research has recently shown tremendous pharmacological usefulness due to the existence of active phytoconstituents. Efforts to create new drug delivery methods, including plant- based antifungals, are underway to improve efcacy against invasive mycoses and reduce high mortality rates; such a system must aid in reducing the time and cost of therapy. Antifungal chemicals can now be carried and released via a wide range of nano- drug delivery systems constructed from lipids, polymers, and metals thanks to advancements in encapsulation and materials science. The possibility of tuning nanostructures having different compositions or surface properties with distinct membrane uidity enables one to utilize them as efcient vehicles for the transport of natural antifungal compounds (Yadav etal., 2022).

10.3.5 aNtioxidaNt Neuroprotective herbal NaNomediciNe

In the medical eld, managing central nervous system (CNS) illnesses, particularly those involv­ing neurodegenerative processes, has traditionally been one of the most difcult challenges. The current drugs available have limited use and are not neuroprotective; in fact, the majority of them have other unwanted side effects. In this setting, there is a growing interest in the research of natu­ral compounds that could serve as neuroprotective treatments for such illnesses, owing to their antioxidant activity. Flavonoid polyphenols such as quercetin, as well as nonavonoids like res­veratrol and curcumin, have been shown to be neuroprotective. Despite their many benets, these chemicals have limited bioavailability and transport into the CNS due to their inability to penetrate the blood–brain barrier. An encouraging approach to counteract these limitations is to employ nano­technology for the preparation of nanoparticles with features that can improve the efciency of these neuroprotectors (Hort etal., 2024). Artichoke agricultural waste has revealed a comprehen­sive and varied herbal remedy for Alzheimer’s disease (AD). This revealed a high concentration of caffeoylquinic acids and avonoid glycosides in the artichoke bracts extract, including apigen­tin, luteolin, kaempferol, and quercetin. It has a signicant amount of total phenolic and avonoid chemicals. Antioxidant activity were determined in vitro using a variety of approaches. Artichoke bract extracts and chitosan- coated solid lipid nanoparticles were tested in vivo for their ability to treat Alzheimer's disease using a streptozotocin- induced mice model. Mice treated with artichoke extract or chitosan- coated artichoke- loaded solid lipid nanoparticles showed improved memory and cognitive functions, as well as down- regulation of inammatory markers and key proteins involved in the progression of Alzheimer’s disease, such as β-amyloid and tau proteins. Furthermore, neuro­protective activity was witnessed in the dentate Gyrus areas of the brain only by histopathological examination (El- Nashar etal., 2022). Zhang et al. found that administering curcumin (CUR) via intranasal route improves its transport into the brain. Curcumin- encapsulated chitosan- coated poly (lactic- co- glycolic acid) nanoparticles (CUR- CS- PLGA- NPs) and hydroxypropyl- β-cyclodextrin- encapsulated curcumin complexes (CUR/HP- β-CD) inclusion complexes improved brain delivery after intranasal administration at the same dose. CUR/HP- β-CD inclusion complexes had greater bioavailability and brain distribution compared to CUR- CS- PLGA- NPs in the same settings. CUR/ HP- β-CD is easier to prepare than CUR- CS- PLGA- NPs. Hence, the former approach is more prac- ticable for industrial magnication (Zhang etal., 2020). Because of their intrinsic potential to boost free radical scavenging activity, antioxidants will be more effective when combined as nanopar­ticles. Moving further, the integration of material science with nanobiotechnology has already been shown to prevent oxidative damage caused by free radicals in living biological systems more
226 Herbal Pharmacopeia
effectively. Antioxidant nanoparticles are expected to outperform all standard antioxidant therapy in terms of improving quality of life and increasing life span. Nanotechnology refers to materials that are specically created and developed to interact with biological systems on a molecular level. This technology has the potential to profoundly change the management of neurodegenerative disorders since it stimulates, responds to, and interacts with any place within the body in such a way as to elicit a required response with minimized unwanted side effects. Without a single doubt, over the past decade, nanotechnology has been hailed and recognized worldwide as a very promising tool for not only the diagnosis but also the treatment of neurodegenerative diseases. Thus, NPs have the potential to revolutionize the course of treatment for diseases like Alzheimer’s disease, Parkinson’s disease, and stroke (Sandhir etal., 2015).

10.3.6 aNti- diabetic herbal NaNomediciNe

Diabetes is a chronic metabolic illness that affects millions of people worldwide and, as a result, contributes signicantly to human mortality. Plant- based therapies have long been used to treat diabetes mellitus around the world. Herbal medicines are one of many medications and alternative therapies that have been shown to be effective in treating and maintaining diabetes without caus­ing side effects. Researchers are seeking for innovative drugs that have maximal efcacy while causing the fewest side effects. Herbal drugs are widely utilized in daily life, are easily accessible, and have few side effects. Nanoscience and nanotechnology are used extensively in a variety of elds, including green chemistry and herbal medicine research. In herbal medicine, the drug will take a longer amount of time. Because herbal- mediated nanoparticles have smaller particles, a big­ger surface area, and enhanced solubility, they may be able to deliver an appropriate therapeutic dosage that can swiftly reach the systemic circulation and the intended location of action. Herbal plant extracts for nanoparticle production are an emerging area of research with enormous potential for the advancement and development of nanomedicine through innovative approaches (Shanker Kalakotla etal., 2015). Bhagwat etal. (2018) demonstrated the manufacture of copper nanoparticles (CuNPs) utilizing extracts from the leaves and peels of the Barleria prionitis, Litchi chinensis, and Platanus orientalis plants. The bioreduction process was quick and efcient, resulting in homog­enous, tiny, and stable copper nanoparticles, which are critical for prospective nanomedicine appli­cations. CuNPs show signicant antidiabetic activity by inhibiting α-amylase and α-glucosidase enzymes. CuNPs produced from Platanus orientalis leaf extract demonstrated the highest level of α-glucosidase inhibition (89.31±0.17%). The CuNPs produced by the Barleria prionitis leaf extract had a slightly lower inhibition of 80.09±1.41%. CuNPs produced from Litchi chinensis peel extract had the strongest inhibition, which was as high as 25.92±1.9%. In contrast, CuNPs generated by Barleria prionitis leaf extract and Platanus orientalis leaf extract showed inhibition at 14.28±1.58% and 13.22±0.52%, respectively. As a result, phytogenic CuNPs have great promise as a therapeu­tic nanomaterial for the treatment of type 2 diabetes mellitus (Bhagwat etal., 2018). Azadirachta indica silver nanoparticles and crude extract can suppress α-amylase activity. AI- AgNPs had higher percent inhibition and a lower IC50 value (48.26 μg/mL) compared to the crude extract (68.37 μg/ mL). Furthermore, diabetic mice’s blood glucose levels were signicantly reduced after 30 days of therapy with AI- AgNPs. The dosage of AI- AgNPs- dependent decrease of hyperglycemia has been identied. The studies indicate that AI- AgNPs are more powerful than the crude extract and can potentially be used for the management of diabetes (Rehman etal., 2023). The study looked at the effect of combination nanoformulations (NFs), including glycyrrhizin (GL)-loaded nanoparticles (NPs) and thymoquinone (TQ)-loaded nanocapsules (NCs), on diabetic rats during a 21-day period. An investigation was carried out to contrast the pure and NF forms, as well as the individual and combined applications. The combined nutraceutical formulations (NFs) of GL and TQ were sig­nicantly more benecial than the separate NFs in terms of lowering fasting blood glucose levels, glycated hemoglobin, enhancing lipid proles, and reducing body weight. Although the pure drug components were reduced, mixed nanobers (NFs) outperformed all examined measures, implying
Applications of Nanotechnology in Herbal Pharmacology 227
increased efcacy and reduced toxicity. These data imply that combining bioactive substances at lower concentrations is more effective than using individual components alone. This highlights the need for more investigation into the synergistic effects of these compounds for the treatment of diabetes (Rani etal., 2019). Several antidiabetic phytochemicals have been produced in nanoscale formulations in this context of medicinal chemistry, with the potential to improve adherence and clinical success. These formulations address concerns with medication transportation and distribu­tion in the body, as well as drug release properties. As a result, the creation of therapeutic nanofor­mulations, including antidiabetic medicines, has enormous potential for increasing their clinical efcacy. However, more research is needed to develop an efcient nanoformulation that succeeds in controlling diabetes and related complications (Dewanjee etal., 2020).

10.3.7 cardioprotective herbal NaNomediciNe

Since the incidence of cardiovascular diseases (CVD) has been excessively high and a main cause of mortality over the last several decades, there is a crucial need to develop methods for preventing and treating CVD. Because of the severe side effects of current treatments, other alternative thera­peutic options, such as medicinal herbs and natural products, are being promoted. As a result, nano­formulation is a pragmatic approach to treatment that tries to reduce therapeutic side effects while also improving drug delivery. As a result, the specic characteristics of the targeted organs serve as recommendations for the sort of nanostructures that must be generated in order to treat diseases. This high order includes nanostructures of organic and inorganic nature designed for the delivery of phytochemicals such as berberine, tilianin, naringenin, gymnemic acid, quercetin, puerarin, scutel­larin, magnolol, breviscapine, resveratrol, and others. Nevertheless, some of its therapeutic poten­tials have been elaborated with regard to nano- curcumin or nano- resveratrol. Nevertheless, available data are not sufcient in the case of CVDs (Hesari etal., 2021). In this context, a dose of 500 mg/ kg body weight of Paeonia emodi’s methanolic extract is thought to offer cardioprotective proper- ties. Among the fractions, the ethyl acetate fraction of P. emodi was the most powerful and is hence chosen for further separation. Pe.EA40 was found to be the most potent subfraction after a scaled­ up screening at 100 mg/kg dosage. Pe.EA40 decreases Lactate Dehydrogenase (LDH), Aspartate Amino Transferase (AST), Creatine Phosphokinase (CPK) and Alanine Amino Transferase (ALT) levels in a dose- dependent manner across all doses ranging from 20 mg/kg to 120 mg/kg. Compared to Pe.EA40, Pe.EA40-AuNPs displayed superior cardio- protective properties, since the above bio­markers have already shown a substantial drop even at a dose of 40 mg/kg, which is half of the dose used in the treatment of Pe.EA40 alone. Better solubility, permeability, and tissue penetration provided by AuNPs could be accountable for enhanced drug delivery and therapeutic efciency (Muhammad etal., 2018). Carbon dots (CDs) were extracted from Curcumae Radix Carbonisata (CRC) hydrolysates after it was observed that the pre- administration of CRC- CDs lowered serum levels of cardiac enzymes and increased the antioxidant capacity of myocardial tissues in rats. One of them may be an excess oxidative stress reducer and a reduced inducer of cardiomyocyte apoptosis in cardiac tissues. CRC- CDs work in tandem with a promising medication candidate to treat myocar­dial ischemia, giving supporting evidence for the expanded use of cardiovascular disease treatment and nanomedicine applications in treating difcult conditions (Dong etal., 2024). Cardiovascular disease remains a leading cause of death around the world. Currently, extensive research is being conducted around the world to discover innovative alternative treatments for cardiovascular disease. Curcumin has demonstrated exceptional therapeutic potential in cardiovascular disease preventive studies, ranging from the preclinical to the clinical stages. It reduces hypercholesterolemia and ath­erosclerosis. Furthermore, it protects against cardiac ischemia and reperfusion. These properties sci­entically validate curcumin (CUR) as an effective treatment for cardiovascular illnesses. However, clinical investigations of curcumin administration revealed a variety of effects on cardiovascular parameters at dosages ranging from 20 to 4,000 mg. One of the most signicant constraints to using CUR as a medical medication is its low absorption. In addition to better targeting, pharmacokinetics,
228 Herbal Pharmacopeia
and efcacy other than cellular absorption, nanomedicine- based formulations of CUR are being developed to overcome this problem. The nanoformulations are representing a new generation of medicinal treatment studies. Further studies should direct new CUR nanomedicines towards inten­sive clinical testing (Salehi etal., 2020).
10.4 ADVANTAGES OF NANOTECHNOLOGY IN HERBAL
PHARMACOTHERAPY

10.4.1 combiNiNg NaNotechNology aNd herbal pharmacotherapy

Combining nanotechnology and herbal pharmacotherapy is a feasible solution to a number of prob­lems that traditional herbal medicine faces. These advancements help to advance integrative and customized healthcare practices by improving the safety and efcacy of herbal medications and expanding their use to a broader spectrum of medical concerns.

10.4.2 eNhaNced bioavailability

The low solubility and absorption of active compounds in herbal medicine raises serious con­cerns about their bioavailability. Nanotechnology has the potential to make herbal extracts more stable and soluble by forming them into small particles or transport systems (such as liposomes or nanoparticles). This enhancement leads to better absorption and utilization of herbal substances in the body. These carriers improve absorption across biological barriers, promote bioavailability, and protect herbal compounds from deterioration in the gastrointestinal system. (Das & Sharangi,
2020).

10.4.3 targeted delivery

It is possible to design nanocarriers that specically target organelles, tissues, or cells in the body. The systemic negative effects of herbal medications are decreased and their therapeutic effective­ness is increased by this tailored distribution. For instance, in cancer treatment, nanoparticles may directly carry herbal ingredients to tumor cells, and in inammatory illnesses, they can deliver them to inamed tissues. Personalized treatment and improved adherence by patients are possible benets of using nanotechnology into herbal preparations (Javed etal., 2020).

10.4.4 improved stability or shelf life

Herbal extracts often degrade quickly, leading to decreased shelf life particularly in the presence of light, air, or changes in temperature. By encapsulating these substances in nanoparticles or covering them with protective layers, nanotechnology may safeguard these substances. The stabilization pro­cess prolongs the shelf life and guarantees the continuous effectiveness of herbal products. Because of this stability, herbal formulations have a longer shelf life and are thus more suited for commercial application (Dewi etal., 2022).

10.4.5 syNergistic effects aNd combiNatioN therapies

Combining several plant extracts or herbs with traditional medications in a single composition is made possible by nanotechnology. This method maximizes therapeutic results by enabling syner­gistic effects and the tailoring of therapy to meet the demands of specic patients. The combined use of certain herbal preparations may have synergistic effects that increase their overall medicinal value. Enhanced therapies and decreased medication resistance may result from such combinations (Anwar etal., 2021).
Applications of Nanotechnology in Herbal Pharmacology 229

10.4.6 reduced dosage aNd toxicity

Nanotechnology improves bioavailability and targets specic regions, allowing herbal medicines to be administered at a lower dose without losing potency. Patients are more likely to stick to their treatment plans when the risk of side effects is reduced. This dose reduction may help lessen the risk of toxicity associated with utilizing high doses of herbal treatments. Herbal compounds can be gen­tly released from nanoparticles, keeping medicinal concentrations for a long period. This delayed release prole decreases dosing frequency and improves patient compliance. (Ahmed etal., 2021).

10.4.7 crossiNg biological barriers

Some herbal compounds have difculties crossing biological barriers, such as the intestinal epithe­lium or the blood–brain barrier. By inventing delivery techniques that make it easier for these drugs to pass over these impediments, nanotechnology may open up new therapeutic paths for maladies including gastrointestinal or neurological problems, as well as prenatal conditions. This concen­trated distribution minimizes potential side effects, reduces the required dose, and boosts the absorp­tion of herbal components. Furthermore, the regulated release kinetics enabled by nanotechnology ensure long- term therapeutic benets. As a result of breaking through biological boundaries, nano­technology is vital to maximizing the safety and effectiveness of herbal medicine, bringing up new possibilities for personalized and successful medical care (Makeen & Barik, 2016).

10.5 CHALLENGES AND LIMITATIONS

Even though nanoparticle- based plant products might have some benets, they also have some prob­lems and safety issues. To make sure that these nanocarriers are safe, more study needs to be done on their toxicity, possible protection, and long- term effects on human health. Challenges related to quality and regulatory aspects hinder the widespread industrialization and adoption of plant- based nanotechnology products.

10.5.1 complexity of herbal systems

One of the main obstacles to using nanotechnology in herbal pharmacology is the inherent high complexity of herbal medications. Herbal medications, in contrast to manufactured treatments, often include a large variety of bioactive substances with distinct physicochemical characteristics. Indeed, molecular size, solubility, stability, and interaction with biological systems may vary signicantly. Hence, the complexity that has to be bargained in order that delivery systems satisfactorily encapsu­late, stabilize, and deliver herbal ingredients to respective targets lies with nanotechnology (Barkat etal., 2020).

10.5.2 bioavailability eNhaNcemeNt

Herbal nanomedicines are very popular in the search for new drugs. Nanotechnology has prof­ited much to the healthcare industry, churning out a good number of innovative nanocarriers that enhance the clinical efcacy and herbal medication bioavailability (Shree etal., 2024). The herbal components ought to be more bioavailable in order to maximize their therapeutic power. Among the more interesting ways in which nano- science is helping herbal medications to become poorly soluble, permeable, and stable are strong lipid nanoparticles, polymeric nanoparticles, and nano­emulsions. However, adequate bioavailability continues to be elusive due to variety factors such as quick clearance from the circulatory system, initial metabolism, and gastric degradation. The complex interaction between biological barriers and nanoparticles requires thorough investigation to ensure safe and effective therapeutic outcomes (Teja etal., 2022).
230 Herbal Pharmacopeia

10.5.3 regulatory aNd ethical coNsideratioNs

Regarding herbal medicine goods, several regulatory frameworks exist around the world. For exam­ple, many of these items lack explicit laws covering formulations including nanotechnology. Herbal nano- pharmaceuticals pose a challenge to regulatory bodies that seek to assess the quality, safety, and efcacy of these products since particular properties and intricate interactions may be unique and complex in this heterogeneous group. As a result, harmonizing the regulatory framework and establishing exact criteria is critical for clinical development, market approval, and, particularly, post- marketing monitoring of herbal nanoparticle products. Furthermore, there are moral concerns about intellectual property rights over these discoveries, fair access to cutting- edge medical technol­ogy, and the preservation of traditional herbal knowledge and practices that are passively passed down or diffused within families or ethnic social groups (Mohi- Ud- Din etal., 2020).

10.5.4 cost aNd scalability

Signicant amounts of money are spent on research and development to create and promote herbal nanotechnology- based products, including the purchase of specialized instruments, nanomaterials, and research. Enhanced product production is always coupled with increasing costs, which poses a difculty in resource- constrained contexts and markets. It appears that nancial challenges have a bearing on issues relating to pricing and access; therefore, this may undermine the successful appli­cation of new nanotechnology solutions to herbal pharmacology (Kumar, 2023).

10.5.5 safety aNd toxicity issues

Nanoparticles utilized in drug delivery systems may be toxic, immunogenic, or accumulate in some essential organs, etc. in a time- dependent manner, some of the associated safety problems. In herbal nanopharmaceuticals, these issues are multiplied manifold due to their interactions with the endog­enous biological molecules and the bioactive phytochemicals. Proper pre- clinical studies will help to establish the safety of nanotechnology- based herbal formulations regarding their pharmacologi­cal biological compatibility and possible undesirable side effects. The authorities must come up with strictly regulated guidelines that consider testing the safety prole of such novel formulations prior to their approval for clinical use and commercialization (Bandakinda etal., 2024). Herbal medications and derivatives have long been used in a variety of global therapeutic systems, includ­ing African, Chinese, Indian, and Sowa- Rigpa. Because of their importance in fundamental medi­cal treatment, conventional medications have remained advantageous in drug research (Naik etal.,
2023).

10.5.6 staNdardizatioN aNd Quality coNtrol

Herbal formulations are already extremely challenging to standardize because of variation in plant species, growth environment, techniques of harvesting, and extraction procedures. Nanoparticles can modify stability and bioactivity of herbal components during formulation and storage; therefore, adding nanotechnology into the mix increases the variability still further. There is a need to develop the standard procedure for the manufacturing, analysis, and quality check of nanotechnology herbal products to ensure medicinal value as well as protection for patients from sample to sample for sta­bility (Wang etal., 2023). Otherwise, standardization of herbal medicines will be purposeless with the growing interest in natural therapies if not directed towards the treatment of disorders caused by the current lifestyles that have become a rampant problem. Diseases in the form of obesity, diabe­tes, cardiovascular problems, and hypertension are global health problems rooted in poor lifestyle. Herbal therapy is sought after by many as an alternative to conventional pharmaceutical therapies because of their drawbacks (Paul & Kumar, 2023).
Applications of Nanotechnology in Herbal Pharmacology 231

10.6 FUTURE PROSPECTS AND TRENDS

Nanotechnology holds potential for herbal medicine if regulatory issues are to be sorted out, and safety must be assured. In addition, the development in nanomaterials and production processes makes feasible the formulation of compositions with better and more specic efcacy from plants. Herein, co- operation would be needed in a big way from pharmaceutical researchers, herbal experts, and nanotechnology experts to be able to fully harness and exploit nanotechnology for the betterment of herbal medicine (Kumar, 2023). It is here with nanotechnology that one can enhance the delivery, effectiveness, and safety proles of herbal medications. The current study of the pharmacological activities of Berberine (BBR) is also active, with several ndings published in journals or presented at international congresses. One potential future application is the isolation or neosynthesis of BBR compounds with higher bioavailability. Another example is that some studies have employed acute, subacute, and subchronic toxicities to evaluate the medical therapeutic efcacy of BBR. This means that an important application is the increased bioavailability achieved through nanoformulations by herbal extracts encapsulation, together with chemicals. It is enveloped to bypass gastrointestinal tract degradation and enhance the process of absorption for systemic circulation. The development removes a long- standing problem in conventional herbal treatment where low bioavailability has too often lim­ited therapeutic effectiveness (Behl etal., 2022). Nanotechnology also makes site- specic transport easier, which means that plant bioactive can only affect the cells or tissues they are supposed to reach, reducing any effects that happen elsewhere. This makes therapy more effective. Improving the physi­cal and chemical qualities of plant extract nanoencapsulation could help control how quickly bioac­tive ingredients are released, allowing for a steady medicinal dose (Teja etal., 2022). Furthermore, nanocarriers have demonstrated the ability to cross the blood–brain barrier; as a result, herbal rem­edies pass through it to treat neurological problems. Aside from improved distribution, nanotechnol­ogy provides instruments of herbal product characterization and standardization that provide quality control and batch- to- batch consistency, which is a very signicant component in regulatory clearance and consumer condence (Wahab et al., 2022). The stabilizing feature that functionalization at a nanoscale level imparts is responsible for increasing the shelf life of herbal formulations from depen­dence on hard chemical preservatives Predictable future developments in herbal pharmacology and nanotechnology could establish new biochemical combination treatments that take advantage of syn­ergistic interactions between herbal extracts and nanoparticles, thereby elevating therapeutic efcacy while reducing total dosage requirements and associated side effects (Anand etal., 2024). However, there is an undeniable need for rigorous scientic control and regulatory administration in areas such as scalability, cost- effectiveness, and safety concerns about the long- term effects of nanomaterial exposure. As this eld expands, herbalists, clinicians, pharmacologists, and nanotechnologists will need to collaborate more than ever to fully realize nanotechnology’s potential to cause a paradigm shift in herbal pharmacology, resulting in a whole new generation of treatments that are personalized, targeted, and effective, tailored to each patient’s needs and way of life. Herbal medicine has nally discovered a new way to work in nanotechnology, making it a strong challenger as an alternative or additional treatment to traditional medications in new healthcare settings (Barkat etal., 2020).

10.7 CONCLUSION

Nanoscience application in herbal medicine has been very promising across various sectors, includ­ing neuroprotection, care for diabetes, antifungal, antibacterial, antioxidant, and cancer treatment. Nanotechnology increases the possibilities of herbal components to be absorbed by the body, deliv­ered target- specic, and protected from breakage, hence increasing their efcacy. Effective delivery of active components from herbal therapies to cancer cells is one of the issues of the conventional form of herbal therapies. This can be achieved through nanocarriers, for example, liposomes, nanoemul­sions, nanocapsules, nanobers, dendrimers, and nanoparticles. Among the avonoid, polyphenols, furocoumarin, psoralen, curcumin, and triptolide has evidence for neuroprotective properties shown
232 Herbal Pharmacopeia
in neurodegenerative diseases, as also with non- avonoids such as resveratrol and curcumin. Their inability to pass the blood–brain barrier restricts their effectiveness. Nanotechnology will be able to navigate this by creating nanoparticles that successfully carry chemicals into the central nervous sys­tem, hence increasing their therapeutic power against diseases such as Alzheimer's. This facilitates the use of nano herbal medicines in the treatment of diabetes without any difculties that may come with pharmaceuticals as a result of limited solubility, thereby boosting their anti- diabetic qualities. This promotes a more effective and constant distribution of active substances, hence leading to improved control over blood glucose levels and fewer side effects about classic therapies. In general, nanosci­ence combined with herbal medicine shows potential for creating improved and safer choices of medi­cation. Nanotechnology breakthroughs improve the pharmacological features of herbal medicines and open further possibilities for other innovative therapies, which may make up a principal inuence on patient care and results. Simultaneously, further research and the promotion of multidisciplinary col­laboration are required to realize the full potential of such innovative therapeutic applications.

REFERENCES

Abo- Zeid, Y., Diab, R., Sanad, R., & Skran, W. (2021). Recent advances in herbal- based nanomedicine for
anti- inammatory purposes. Journal of Advanced Pharmacy Research, 5(4), 387–397. https://doi. org/10.21608/aprh.2021.79946.1135
Afroj, S. C., Babar, A. S., Dahiwade, L. K., Payghan, S. A.. (2021). Recent advances in herbal nanotechnology.
International Journal of Creative Research Thoughts 9(5), 312–321.
Ahmed, H. M., Nabavi, S., & Behzad, S. (2021). Herbal drugs and natural products in the light of nanotechnol-
ogy and nanomedicine for developing drug formulations. Mini- Reviews in Medicinal Chemistry, 21(3), 302–313. https://doi.org/10.2174/1389557520666200916143240
Anand, A., Gautam, P., & Ojha, S. (2024). Application of nanotechnology for herbal medicine development:
A review. Letters in Drug Design & Discovery, 21(8), 1325–1333. https://doi.org/10.2174/1570180820 666230308105723
Ansari, S.H., Islam, F., Sameem, M. (2012). Inuence of nanotechnology on herbal drugs: A Review. Journal
of Advanced Pharmaceutical Technology & Research 3, 142–146.
Anwar, D. M., El- Sayed, M., Reda, A., Fang, J.-Y., Khattab, S. N., & Elzoghby, A. O. (2021). Recent advances
in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes. Expert Opinion on Drug Delivery, 18(11), 1609–1625. https://doi.org/10.1080/17425247.2021.1955853
Arin, S.F., AlShami, A., Omar, S.S.S., Jalil, M.A.A., Khalid, K.A., Hadi, H. (2019). Impact of modern tech-
nology on the development of natural- based products. International Journal of Ayurvedic And Herbal Medicine 5(4), 133–142.
Attallah, N. G. M., Elekhnawy, E., Negm, W. A., Hussein, I. A., Mokhtar, F. A., & Al- Fakhrany, O. M. (2022).
In vivo and in vitro antimicrobial activity of biogenic silver nanoparticles against staphylococcus aureus clinical isolates. Pharmaceuticals, 15(2), 194. https://doi.org/10.3390/ph15020194
Bala, N., Saha, S., Chakraborty, M., Maiti, M., Das, S., Basu, R., & Nandy, P. (2015). Green synthesis of
zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: Effect of temperature on synthesis, anti­bacterial activity and anti- diabetic activity. RSC Advances, 5(7), 4993–5003. https://doi.org/10.1039/ C4RA12784F
Bandakinda, M., Kumar, A., & Mishra, A. (2024). Toxicity issues of nanoparticles in the delivery of phytocon-
stituents and cosmeceuticals. In Nanotechnology Based Delivery of Phytoconstituents and Cosmeceuticals (pp. 329–342). Springer Nature Singapore. https://doi.org/10.1007/978-981-99-5314-1_11
Barkat, M. A., Harshita, D. S. S., Beg, S., & Ahmad, F. J. (2020). Nanotechnology- based phytotherapeu-
tics: Current status and challenges. In Nanophytomedicine (pp. 1–17). Springer Singapore. https://doi. org/10.1007/978-981-15-4909-0_1
Baskaran, M., Baskaran, P., Arulsamy, N., & Thyagarajan, B. (2017). Preparation and evaluation of PLGA-
coated capsaicin magnetic nanoparticles. Pharmaceutical Research, 34(6), 1255–1263. https://doi. org/10.1007/s11095-017-2142-2
Behl, T., Singh, S., Sharma, N., Zahoor, I., Albarrati, A., Albratty, M., Meraya, A. M., Najmi, A., & Bungau, S.
(2022). Expatiating the pharmacological and nanotechnological aspects of the alkaloidal drug berberine: Current and future trends. Molecules, 27(12), 3705. https://doi.org/10.3390/molecules27123705
Applications of Nanotechnology in Herbal Pharmacology 233
Bhagwat, T. R., Joshi, K. A., Singh Parihar, V., Asok, A., Bellare, J., & Ghosh, S. (2018). Biogenic copper
nanoparticles from medicinal plants as novel antidiabetic nanomedicine. World Journal of Pharmaceutical Research, 7, 183. https://doi.org/10.20959/wjpr20184-10773
Bitencourt, P. E. R., Ferreira, L. M., Cargnelutti, L. O., Denardi, L., Boligon, A., Fleck, M., Brandão, R.,
Athayde, M. L., Cruz, L., Zanette, R. A., Alves, S. H., & Moretto, M. B. (2016). A new biodegradable polymeric nanoparticle formulation containing Syzygium cumini: Phytochemical prole, antioxidant and antifungal activity and in vivo toxicity. Industrial Crops and Products, 83, 400–407. https://doi. org/10.1016/j.indcrop.2016.01.007
Borase, V.A., Kapadnis, R. S., Chaudhari, A. Y., Bachhav, R. S. (2020). A review on novel drug delivery system.
Journal of Emerging Technologies and Innovative Research 7(9), 19–27.
Bruna, Vidal Bonifácio etal. (2014). Nanotechnology- based drug delivery systems and herbal medicines: a
review. International Journal of Nanomedicine. 9, 1–15.
Chakraborty, K., Shivakumar, A., Ramachandran, S. (2016). Nano- technology in herbal medicines: A review.
International Journal of Herbal Medicine 4(3), 21–27.
Chaudhary, H., Kohli, K., & Kumar, V. (2013). Nano- transfersomes as a novel carrier for transdermal delivery.
International Journal of Pharmaceutics, 454(1), 367–380. https://doi.org/10.1016/j.ijpharm.2013.07.031
Chaudhary, H., Kohli, K., & Kumar, V. (2014). A novel nano- carrier transdermal gel against inammation.
International Journal of Pharmaceutics, 465(1–2), 175–186. https://doi.org/10.1016/j.ijpharm.2014.02.023
Cinthura, C., & Rajasekar, A. (2020). Antibacterial activity of cinnamon- Clove mediated silver nanoparticles
against Streptococcus mutans. Plant Cell Biotechnology and Molecular Biology 21, 11–17.
Coradini, K., Friedrich, R. B., Fonseca, F. N., Vencato, M. S., Andrade, D. F., Oliveira, C. M., Battistel, A. P.,
Guterres, S. S., da Rocha, M. I. U. M., Pohlmann, A. R., & Beck, R. C. R. (2015). A novel approach to arthritis treatment based on resveratrol and curcumin co- encapsulated in lipid- core nanocapsules: In vivo studies. European Journal of Pharmaceutical Sciences, 78, 163–170. https://doi.org/10.1016/j.ejps.
2015.07.012
Cui, M., Wu, W., Hovgaard, L., Lu, Y., Chen, D., & Qi, J. (2015). Liposomes containing cholesterol analogues
of botanical origin as drug delivery systems to enhance the oral absorption of insulin. International Journal of Pharmaceutics, 489(1–2), 277–284. https://doi.org/10.1016/j.ijpharm.2015.05.006
Das, S., & Sharangi, A. B. (2020). Nanotechnology: A potential tool in exploring herbal benets (pp. 27–46).
https://doi.org/10.1007/978-3-030-41464-1_2
Dellali, K. Z., Rata, D. M., Popa, M., Djennad, M., Ouagued, A., & Gherghel, D. (2020). Antitumoral
drug: Loaded hybrid nanocapsules based on chitosan with potential effects in breast cancer therapy. International Journal of Molecular Sciences, 21(16), 5659. https://doi.org/10.3390/ijms21165659
Deng, S., Gigliobianco, M. R., Censi, R., & Di Martino, P. (2020). Polymeric nanocapsules as nanotechno-
logical alternative for drug delivery system: Current status, challenges and opportunities. Nanomaterials, 10(5), 847. https://doi.org/10.3390/nano10050847
Dewanjee, S., Chakraborty, P., Mukherjee, B., & De Feo, V. (2020). Plant- based antidiabetic nanoformulations:
The emerging paradigm for effective therapy. International Journal of Molecular Sciences, 21(6), 2217. https://doi.org/10.3390/ijms21062217
Dewi, M. K., Chaerunisaa, A. Y., Muhaimin, M., & Joni, I. M. (2022). Improved activity of herbal medicines
through nanotechnology. Nanomaterials, 12(22), 4073. https://doi.org/10.3390/nano12224073
Dilnawaz, F., & Sahoo, S. K. (2013). Enhanced accumulation of curcumin and temozolomide loaded magnetic
nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model. European Journal of Pharmaceutics and Biopharmaceutics, 85(3), 452–462. https://doi.org/10.1016/j.ejpb.2013.07.013
Dong, L., Zhao, Y., Luo, J., Li, X., Wang, S., Li, M., Zou, P., Kong, H., Wang, Q., Zhao, Y., & Qu, H. (2024).
Carbon dots derived from curcumae radix and their heartprotective effect. International Journal of Nanomedicine, 19, 3315–3332. https://doi.org/10.2147/IJN.S444125
Dubey, S. K., Parab, S., Achalla, V. P. K., Narwaria, A., Sharma, S., Jaswanth Gowda, B. H., & Kesharwani, P.
(2022). Microparticulate and nanotechnology mediated drug delivery system for the delivery of herbal extracts. Journal of Biomaterials Science. Polymer Edition, 33(12), 1531–1554. https://doi.org/10.1080 /09205063.2022.2065408
Elgohary, M. M., Helmy, M. W., Abdelfattah, E.-Z. A., Ragab, D. M., Mortada, S. M., Fang, J.-Y., & Elzoghby,
A. O. (2018). Targeting sialic acid residues on lung cancer cells by inhalable boronic acid- decorated albu­min nanocomposites for combined chemo/herbal therapy. Journal of Controlled Release, 285, 230–243. https://doi.org/10.1016/j.jconrel.2018.07.014
Elmarzugi, N., Amara, R., Eshmela, M., & Eid, A. (2023). An overview of nanocapsule and lipid nanocap-
sule: Recent developments and future prospects. Palestinian Medical and Pharmaceutical Journal, 8(3). https://doi.org/10.59049/2790-0231.1244